chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Eyes rolled to back of head, hands to side and convulsed for 17-20 seconds, clammy, unconscious, pt unaware of surroundings post convulsions and or name, pt urinated on self, pt was nauseous and dizzy, symptoms began 5 minutes after vaccination and pt was discharged one hour later.
Difficulty breathing. Felt like an severe asthma flare up probably would. Lasted all night. I was better in the morning. Unknown what type of Influenza vaccine it was.
Initial fever, then dizziness, disorientation, and delusional thinking.  No treatment given to date.  Neurology specialty evaluation pending.
Red, raised rash on belly and upper back and cheeks.  No meds. Temp. 103.6.
Same day as injection I had a sore throat and covid arm started to form.  My sore throat proceeded to tighten every day, treated with Benadryl and Tylenol every day. My throat closed more on 8/14/21 felt my chest tighten, hard to breathe so I went to urgent care they prescribed me MethylPREDNISolone Tablets 4 mg per tablet 21 Tablets 6 days along with Benadryl, covid arm grew and got intensely itchy. Symptoms still persist even with treatment.
Arthritic like joint pain in both shoulders, neck, and left knee. Patient recovered from the initial acute symptoms, but continues to experience periodic flare-ups of the symptoms - he states arthritis of right shoulder, neck and left knee diagnosed.
Patient states that night after 8/19/08 she started having joint pain. 2/9/09-records received-11/26/08 presented with C/O joint pain, hands, legs, feet since 8/19/08 per parent. Parent saw TV program about similar problems and wants something done today. PE normal. Per patient 2 weeks of arthralgia after vaccination. No further visits documented.
Narrative:  COVID infections following completion of COVID vaccine series 01/22/21 COVID dose #1 02/12/21 COVID vaccine dose #2 05/19/21 Pt admitted for right hemicolectomy for adenocarcinoma identified by recent EMR colonoscopy 05/24/21 Pt recovering from surgery 05/25/21 Discharged from hospital 07/08/21 Pt presents to ER reporting increased urinary frequency, blood in urine, and feeling bloated x2-3; discharged home with rx for UTI with cephalexin and phenazopyridine 07/19/21 Pt presents to ED reporting loss of energy and weakness; CT chest atypical infection or aspiration; discharged with rx for augmentin, oxymetazoline nasal spray for possible lung infection, decreased metoprolol dose to 50 mg due to presenting bradycardia and near syncope 07/26/21 Pt's wife was positive; pt tested - COVID NEGATIVE 07/13/21 Pt tested again - COVID POSITIVE; reports asymptomatic; rx given ascorbic acid, cholecalciterol, zinc 08/01/21 Pt reports fatigue, runny nose 08/02/21 Pt reports worsening runny nose, congestion 08/03/21 Pt is improvingl met CDC guidelines for stopping isolation
Severe, heavy fatigue set in about 1.5 hrs. after injection. This caused me to be ineffective and sleep for four hours. Still slept all night that night. Woke the next morning with migraine headache causing mild nausea. Severe body aches in my muscles, joints and bones. Developed a 100.2 fever. Symptoms not relieved by extra strength Tylenol or Motrin 800mg.  Heavy fatigue and pain continued all day and into the second night. Second morning body aches are mild and headache is constant but no longer limiting.
1st symptom - headache at 3pm, then fatigue and body ache at 10pm. Saturday June 5- I woke up with chills, fever and pain in the body. Advil was not working and I switched to Tylenol. 6pm I felt tense muscles and difficult to move; the area of ??the vaccine red, swollen, hot and larger than a quarter - I took Benadryl. Sunday June 6 with Benadryl when waking up with tense muscles, headache and itching in the area of ??the vaccine. By 6pm I just feel itchy and the area of ??the vaccine is still swollen, red.
Information has been received from a nurse in office concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot number not reported). The patient had syncopal events after vaccination and hit her head while walking back to the reception desk. It was unknown if medical attention was sought. The outcome of the patient was not reported. This is one of several reports from the same source. Additional information has been requested.
Patient states had tremors, violent shaking, nausea and vomiting for 6 hours after vaccination
One day following vaccine admin I broke out into a rash of itchy, red bumps on my arms and legs and back.  My upper buttocks on both sides broke out into a flat, solid, red itchy rash  that started spreading downward. I also developed clusters of large hives on my left hip
First dose of the Moderna Covid-19 vaccine administered to a 16 year old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose of the Moderna Covid-19 vaccine administered to a 16 year old) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety, Depression and ADHD.    On 07-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose of the Moderna Covid-19 vaccine administered to a 16 year old). On 07-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose of the Moderna Covid-19 vaccine administered to a 16 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient was not on any medications. The reporter also confirmed that the patient did not experience any side effects.  A VAERs report was sent by the reporter to the Centers for Disease Control and Prevention (CDC) (VAERs number not provided). The second dose of vaccine was not scheduled at the time of reporting and no treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Patient demographics, medical history and vaccine details were updated. On 30-Jun-2021: No new information was received.
Joint Pain; Muscle Pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain). At the time of the report, ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain) had not resolved.            Concomitant medications were not reporter.  Treatment details not provided.
Burning pain at injection site spread to entire arm; 2.5 weeks later (~10/26/2009), developed bilateral lower leg paresthesia. Initially, symptoms included tingling, then numbness, followed by burning. Symptoms developed over a month and have been present daily since. Symptoms are sensory (never lost reflexes), in lower legs, very uncomfortable. Arm is better, but continues to hurt. Treatment: Neurontin.
Employee developed fever & chills, body aches next morning post vax, no localized redness noted but left arm very sore.
pt began oral typhoid 29JUN doses 1JUl, 3JUL, 5JUL sx 10JUL94 nausea, joint aches, h/a, dizziness, emesis; required IV replacement therapy
Was able to drive home and finish work until around 7 pm. At which time I had continuous vomiting and diarrhea for an hour. Afterwards I would have a loose bowl movement and vomiting once an hour through the night until around 2am. At this time the stomach problems seemed to space out 2 hours, then 3, hours. the last of the vomiting and diarrhea ended at 12 noon the following day. Some time in the night I had also developed a mild fever of 100 degrees and a headache, which didn't clear until the 31st.  At one point I thought I might have seen blood in the bile, but I was not positive and the same coloring didn't appear again. I also experienced chills intermittently.
Pericarditis associated with myocardial infarction.  He felt a lot of pressure on his chest as if someone was standing on his chest.  He had a lot of pain.
Child rec'd VARIVAX and HAV; left office and then returned with difficulty breathing shortness of breath, cough, Red itchy palms given EPINEPHRINE in office and taken to ER.
Stated she received the flu vaccine and 1 hour later she was having nausea and vomiting, chills. 24 hr after giving the shot she stated she felt better.
The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM; Dose administered past manufactures expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past manufactures expiration date) and PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination.     It was unknown if patient had allergies to medications, food and other products. It was unknown if patient had diagnosed with or tested positive for COVID-19. It was unknown if patient had acute illness at the time of vaccination and up to one month before.  Concurrent medical conditions included Cerebral palsy.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 03-May-2022 at 2:20 PM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 03-May-2022 at 2:20 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past manufactures expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered past manufactures expiration date) and PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (Dose administered past manufactures expiration date) to be related. No further causality assessment was provided for PRODUCT STORAGE ERROR (The vial expired on 02May2022, was pulled from freezer at 10AM on 03May2022 and was put in refrigerator until approximately 1:45 PM).    No concomitant product reported by reporter.  Prescriptions, over-the-counter medications, dietary supplements, herbal remedies being taken at the time of vaccination and or at the time of adverse event was reported as unknown. It was unknown if patient experienced similar adverse event in the past. Vaccine did not undergone any temperature excursion issue. Vaccine was pulled from freezer at 10AM on 03 May 2022 and was put in refrigerator until approximately 1:45 PM.  No treatment medication reported by reporter.
three year patient received Fluzone High-Dose Quadrivalent vaccine/ NO AE; three year patient received Fluzone High-Dose Quadrivalent vaccine/ NO AE; Initial information received on 03-Sep-2020 regarding an unsolicited valid non-serious case from a nurse.  This case is linked to case ID 2020SA243060, 2020SA242187, 2020SA242315, 2020SA242186 and 2020SA242184.  This case involves a 3-year-old male patient who received once 0.7 mL INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (prefilled syringe, batch number: UJ450AB, expiry date: 30-Jun-2021, via an intramuscular route in left thigh) (overdose and product administered to patient of inappropriate age) on 31-Aug-2020 for prophylactic vaccination.  The patient's medical history, past medical treatment, family history were not provided.  No vaccination and concomitant medications were given.  It was an actual medication error case due to inappropriate age at vaccine administration and overdose (latency : same day).  Reported wanted to know possible side effects.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report was received from a registered nurse and refers to a 8 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 29-NOV-2016, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(manufacturer unknown), lot # M015735 with expiration date of 30-MAR-2018 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 63 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter.
3/26/2021 Note    Nursing Assessment:                Patient called through Office line                Reason for Call  WHEEZING                  Onset: 2 days ago                Occurrence:   acute                Anatomical Location : na                Severity:  moderate                Symptoms:  Patient concerned about having asthma exacerbation.  Started with cough and wheezing 2 days ago.  Cough is productive but has not visualized the sputum.  No fever.  Having intermittent chest achiness in center of chest also.  No known covid exposure.  Had 2nd covid vaccine 2 days ago and states that 2-3 hours after the vaccine she began to have a "wheezing attack" and then it has continued since.  Currently able to talk in full sentences but wheezing and having some breathing difficulty.   Has not used Albuterol since last night.                  Any treatment So Far: Pulmicort, Spriva, and Albuterol                Response:  Helps for a little bit  3/26/2021  ED Visit CHIEF COMPLAINT: RESPIRATORY DISTRESS (began yesterday; says had 2nd covid vaccine weds and believes it "sparked my asthma"; hx of asthma/COPD. associated midsternal chest tightness) DIAGNOSIS at time of disposition:   1. COVID-19 ruled out  2. Bilateral pleural effusion  3. Acute cystitis without hematuria   EKG NSR Chest x-ray showed no acute abnormalities showed stable mild cardiomegaly.  CT results showed new small bilateral pleural effusions, right greater than left.  Minimal bibasilar atelectasis mucus plugging.  No airspace consolidation or PE noted.  Patient reports that she was recently taken off her Lasix secondary to some weight loss and the fact that she had recently had surgery and oral intake was low.  At this time, I do feel some of her symptoms may be related to fluid overload.   Discharge  3/26/2021  3:59 PM 3/28 ED follow up.  Pos urine cx.  ABX started 3/29/2021 Called nurse triage.  MODERATE difficulty breathing (e.g., speaks in phrases, SOB even at rest, pulse 100-120) of new onset or worse than normal.  Told to go to ED.   3/29/2021 ED to hosp admission 28 hours. The encounter with the patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care shortness of breath, anxiety, UTI, recent surgical intervention for bowel obstruction.
24 hours after receiving the first does of Pfizer I experienced a sharp stabbing pain in my heart. I felt about 7 to 8 more stabbing pains in my heart over the next 24 hours. Over the next few days there was a slight pressure on my heart that felt like someone was cupping my heart but was not painful. On the 6th day the pressure built up and it felt like my heart was being squeezed. I had chest tightness, chest pain, heart pain, upper back tightness, upper back pain, a few shooting pains in my jaw and left arm and slight neck tightness. It hurt more when lying down or leaning forward. I went to the Urgent Care on the 7th day. My blood pressure was slightly elevated at 146/81 and my pulse was 94. I was advised to take a over the counter painkiller such as Tylenol for possible inflammation. I have taken Tylenol that somewhat helps the pain and tightness. If I stop taking the Tylenol for 12 hours the heart pain and chest pain come back. Most of the pain and unusual feeling is in my upper left chest but sometimes I have an indescribable pain in the center of my chest. I have felt like I am about to have some sort of heart failure. I have fatigue and light headedness. It is day 15 and I still have chest and heart pain which greatly increases without Tylenol. I was referred to and have scheduled an appointment with a cardiologist on October 15th which I was told was the earliest I could be seen.
Pt w/ hx of allergy to Amoxicillin (anaphylaxis, lip/face swelling).  Pt c/o dizziness at 1410.  Pt had a syncopal episode for a few seconds and woke up when reclined. Patient is A/O x4. Patient is cooperative, and denies pain or SOB. VS taken at triage, BP 86/54, HR 60, O2 97, RR 20, Temp 97.3. CN, nurse, and onsite provider were notified. Pt reports sweating, but denies tremor, numbness, tingling, nausea or vomiting. Offered juice and cracker to pt, no new medication ordered. VS repeated at 1420, BP 111/93, HR 85, O2 97, RR 16. pt reports improvement and denies dizziness, pt left triage with steady gait with family at 1430 and have further observation. Pt left clinic with family. Pt was advised to seek for emergency service if s/s worsen. All needs met, safety maintained.
Patient was given a Moderna vaccine instead of the flu shot that he had come in for.  Patient had already received 2 doses of Pfizer with the last one being administed 9 weeks previous.
This spontaneous report as received from a 70 year old female patient with diabetes and drug reactions/allergies to sulfa drugs refers to herself. The patient's medical  history included shingles 4 times, but she never ran a fever. On 31-MAY-2012 the patient was vaccinated with ZOSTAVAX (dose, route and lot #  not reported). Concomitant therapies included insulin, pravastatin sodium, VISACOR (EPANOLOL). On unknown date in September 2013 the patient experienced severe pain and a rash on her back. She also developed pain from her ear to  nose described as "felt like little ants" sensation and a lesion on her back. The patient went to emergency room but she was not admitted. Do doctor did not identify the symptoms as shingles. The patient reported that the events were not as severe as prior to receiving ZOSTAVAX. On unknown date blood work was made, but the results were not reported. The patient recovered on unknown date from all adverse events. Causality between the events and ZOSTAVAX was not specified. Additional information is not expected as the patient did not provide doctor's contact details.
Case number PHEH2014US024328, is an initial spontaneous report received from a nurse on 02 DEC 2014 with a follow up information received from the nurse on 19 JAN 2015. This report refefs to a 12 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN 2013/2015 (seasonal influenza vaccine, batch number: 14511P expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml in the right deltoid on 05 NOV 2014 at 7:00. It was reported that the patient received FLUVIRIN pre-filled syringe (PFS) that was stored at 49 degree F for 1  hour 15 minutes. The reported confirmed tha thte patient did not experience any adverse reaction following administration of incorrectly stored vaccine. Follow up information received from the nurse on 19 JAN 2015: Updated site of vaccination and reporter's comment.
temp of 102 & body aches x 24 hours. Worst headache of my life x 4 days. It was hard to find any medication to take the headache away completely.
Low grade (99.9*) Fever; Injection Site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248); via unspecified route of administration in the left arm on 25Mar2021 (at the age 50-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955); via unspecified route of administration in the left arm on 04Mar2021 (at the age 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have a history of allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 01:30, the patient had experienced low grade fever (99.9) and injection site pain. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of low-grade fever and injection site pain. The clinical outcome of the events low grade (99.9) fever and injection site pain was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Our patient received dose 1 of the Moderna COVID19 vaccine on 2/12/21 and he was diagnosed with COVID19 on 3/9/21.  Patient admitted to the hospital for a diabetic foot infection and COVID19 was diagnosed upon admission.
Patient presented to the ED on 3/18/21 with syncope. Patient presented to the ED and was subsequently hospitalized on 4/14/21 with sinus pause, syncope.
4 days p/shots? convuls sx's in 4 days; eyes rolled back w/sz like movements;